BCAT1 and central nervous system cancer: Inhibition of BCAT1 in glioma cell lines blocked glutamate excretion and resulted in decreased proliferation and invasiveness in vitro, as well as a significant decrease in tumor growth in a glioma xenograft model, indicating a central role of BCAT1 in glioma pathogenesis (Tönjes et al., 2013).